• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Endocrinology

Ultrasound useful for risk stratification after nondiagnostic thyroid biopsy

byXiaofan PanandAaron Maxwell, MD
August 24, 2014
in Endocrinology, Imaging and Intervention, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Among patients with a nondiagnostic fine needle aspiration biopsy (FNAB) of thyroid nodules, the use of an ultrasound-based evaluation tool appropriately stratified patients according to malignancy risk. 

2. Results suggest that thyroid nodules with two or more suspicious ultrasound features should undergo repeat FNAB, while those with fewer than two suspicious features can be followed with ultrasound. 

Evidence Rating Level: 3 (Average)        

Study Rundown: Evaluation of patients with thyroid nodules typically includes FNAB, an approach critical for the detection of cancer. Although the majority of biopsies are adequate for a cytological diagnosis, up to 21% will be nondiagnostic. These biopsies represent a significant problem, and the management of thyroid nodules in which FNAB is nondiagnostic remains controversial. This study examined the usefulness of repeat FNAB in detecting malignancy in nondiagnostic thyroid nodules in relation to the thyroid imaging reporting and data system (TIRADS), a classification scheme for malignancy risk based on abnormalities and suspicious features detected via ultrasound. Nondiagnostic thyroid nodules were evaluated retrospectively according to TIRADS, and malignancy risk was calculated for nodules in each TIRADS categories. Results of the investigation suggest that TIRADS can appropriately stratify patients according to their risk of thyroid malignancy. Based on this, the authors suggested that for nodules with fewer than two suspicious features can be followed with ultrasound, while those with two or more may benefit from repeat FNAB. This study is limited in its retrospective nature, which may have introduced selection bias when considering how nodules were categorized in the analysis. Additionally, the number of nodules across each TIRADS category varied, which may have impacted the significance of the findings.

Click to read the study in Radiology

Relevant Reading: Thyroid imaging reporting and data system for US features of nodules: a step in establishing better stratification of cancer risk

In-Depth [retrospective cohort]: The medical records of 530 patients (430 women, 100 men) with nondiagnostic thyroid FNABs were retrospectively reviewed, with a total cohort of 548 nodules (7.3% malignant, 92.7% benign). Malignancy risk for the nodules was stratified into TIRAD categories based on suspicious ultrasonography findings such as hyper- and hypo- echogenicity, atypical internal variation, calcifications, irregular margins and abnormal shape. The malignancy risks of categories 3 and 4a nodules were 0.8% and 1.8%, respectively, while malignancy risks for higher TIRADS categories of 4b, 4c, and 5 nodules were 6.1%, 14.4%, and 31%. Researchers in this study also classified nodules according to size (294 larger than 10mm, 254 10mm or smaller). Among nodules >10mm, the malignancy risks of categories 3, 4a, 4b, 4c, and 5 nodules were 0.9%, 1.3%, 0%, 15%, and 33%, respectively. Among nodules ≤10 mm, the malignancy risks of categories 3, 4a 4b, 4c, and 5 nodules were 0%, 2.7%, 14%, 14.3%, and 31%.

RELATED REPORTS

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

More permissive parameters for active surveillance eligibility is potentially possible in slow-growing thyroid cancers

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance

More from this author: Mammography linked to improved breast cancer outcomes among women 75 and older

Image: CC/Wiki

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: thyroid cancerultrasound
Previous Post

Association of obesity and dementia varies with age

Next Post

Suicide tourism increases in Switzerland

RelatedReports

Patient Basics: Thyroid Cancer
Chronic Disease

Fine needle biopsy remains a reliable test for thyroid cancer diagnosis

October 19, 2022
Oncology

More permissive parameters for active surveillance eligibility is potentially possible in slow-growing thyroid cancers

September 26, 2022
Screening insufficient for newborns exposed to hepatitis C virus
Chronic Disease

Impact of ultrasonographic blind spots for early-stage hepatocellular carcinoma during surveillance

September 19, 2022
Artificial-intelligence, deep-learning algorithm identifies papilledema from fundus photographs
Ophthalmology

Optic nerve subarachnoid space area may be an accurate marker for intracranial pressure

August 31, 2022
Next Post
Suicide tourism increases in Switzerland

Suicide tourism increases in Switzerland

High cumulative-dose isotretinoin treatment decreases risk of acne relapse

Severe acne linked to endometriosis

Patients with late stage melanoma remain at risk for further primary melanoma

Key characteristics of high mitotic rate melanoma elucidated

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • SAR-CoV-2 infection during pregnancy may lead to adverse neurodevelopmental outcomes in male offspring
  • Hyperfractionated radiotherapy reduces complication rates compared to standard fractionation for locally advanced nasopharyngeal carcinoma
  • Lebrikizumab effective in treating moderate-to-severe atopic dermatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options